Patents Assigned to Luxena Pharmaceuticals, Inc.
  • Patent number: 9918971
    Abstract: Aerosol formulations of granisetron useful for pulmonary delivery are provided. The formulations are useful in the reduction, elimination or prevention of nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. Also provided are novel methods to treat chemotherapy-induced nausea and vomiting (CINV), radiation-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV) using the inhalation formulations.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: March 20, 2018
    Assignee: LUXENA PHARMACEUTICALS, INC.
    Inventors: George Lu, Xiaodong Li, Biao Lu
  • Patent number: 9770409
    Abstract: Aerosol formulations of ondansetron useful for pulmonary delivery are provided. The formulations are useful in the reduction, elimination or prevention of nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. Also provided are novel methods to treat chemotherapy-induced nausea and vomiting (CINV), radiation-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV) using the inhalation formulations.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: September 26, 2017
    Assignee: LUXENA PHARMACEUTICALS, INC.
    Inventors: Xiaodong Li, George Lu, Biao Lu
  • Publication number: 20150010632
    Abstract: Aerosol formulations of granisetron useful for pulmonary delivery are provided. The formulations are useful in the reduction, elimination or prevention of nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. Also provided are novel methods to treat chemotherapy-induced nausea and vomiting (CINV), radiation-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV) using the inhalation formulations.
    Type: Application
    Filed: July 3, 2014
    Publication date: January 8, 2015
    Applicant: Luxena Pharmaceuticals, Inc.
    Inventors: George Lu, Xiaodong Li
  • Publication number: 20150010633
    Abstract: Aerosol formulations of ondansetron useful for pulmonary delivery are provided. The formulations are useful in the reduction, elimination or prevention of nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. Also provided are novel methods to treat chemotherapy-induced nausea and vomiting (CINV), radiation-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV) using the inhalation formulations.
    Type: Application
    Filed: July 3, 2014
    Publication date: January 8, 2015
    Applicant: Luxena Pharmaceuticals, Inc.
    Inventors: Xiaodong LI, George Lu